<?xml version='1.0' encoding='UTF-8'?>
<extracted-tables-set><pmcid/><all-ids><article-id xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" pub-id-type="pmcid">PMC5561637</article-id><article-id xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" pub-id-type="pmcid-ver">PMC5561637.1</article-id><article-id xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" pub-id-type="pmcaid">5561637</article-id><article-id xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" pub-id-type="pmcaiid">5561637</article-id><article-id xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" pub-id-type="pmid">28818116</article-id><article-id xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" pub-id-type="doi">10.1186/s13195-017-0292-4</article-id><article-id xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" pub-id-type="publisher-id">292</article-id></all-ids><extracted-table><table-id>Tab1</table-id><table-label>Table 1</table-label><table-caption>Subjects’ clinical and demographic features</table-caption><table-wrap-foot>Abbreviations: AD Alzheimer’s disease, AD + CeVD Alzheimer’s disease with cerebrovascular disease, ANOVA Analysis of variance, C/N Chinese/non-Chinese, CDR-SB Clinical Dementia Rating Sum of Boxes, HC Healthy control subjects, MMSE Mini Mental State Examination, VaD Vascular dementia, WMH White matter hyperintensityValues represent mean (SD). The WMH visual rating was measured by the age-related WM change scale score. A subset of patients with complete cognitive scores was used for brain-cognition association analysesa Group mean was different from HC on the basis of post hoc pairwise comparisons (p &lt; 0.05)b Group differences at p &lt; 0.05 significance levelc Group mean was different from the AD group (p &lt; 0.05)</table-wrap-foot><original-table><table-wrap xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" id="Tab1" position="float" orientation="portrait"><label>Table 1</label><caption><p>Subjects’ clinical and demographic features</p></caption><table frame="hsides" rules="groups"><thead><tr><th colspan="1" rowspan="1">Groups</th><th colspan="1" rowspan="1">HC (<italic toggle="yes">n</italic> = 30)</th><th colspan="1" rowspan="1">AD (<italic toggle="yes">n</italic> = 41)</th><th colspan="1" rowspan="1">AD + CeVD (<italic toggle="yes">n</italic> = 25)</th><th colspan="1" rowspan="1">VaD (<italic toggle="yes">n</italic> = 19)</th><th colspan="1" rowspan="1">Overall ANOVA (<italic toggle="yes">F</italic> test)</th></tr></thead><tbody><tr><td colspan="1" rowspan="1">Age, years</td><td colspan="1" rowspan="1">71.4 (6.7)</td><td colspan="1" rowspan="1">74.9 (8.0)</td><td colspan="1" rowspan="1">75.7 (5.3)</td><td colspan="1" rowspan="1">74.1 (7.2)</td><td colspan="1" rowspan="1">2.4</td></tr><tr><td colspan="1" rowspan="1">Sex, F/M</td><td colspan="1" rowspan="1">15/15</td><td colspan="1" rowspan="1">15/26</td><td colspan="1" rowspan="1">8/17</td><td colspan="1" rowspan="1">11/8</td><td colspan="1" rowspan="1">χ<sup>2</sup> = 4.3</td></tr><tr><td colspan="1" rowspan="1">Handedness, L/R</td><td colspan="1" rowspan="1">3/27</td><td colspan="1" rowspan="1">0/41</td><td colspan="1" rowspan="1">0/25</td><td colspan="1" rowspan="1">0/19</td><td colspan="1" rowspan="1">–</td></tr><tr><td colspan="1" rowspan="1">Ethnicity, C/N</td><td colspan="1" rowspan="1">28/2</td><td colspan="1" rowspan="1">33/8</td><td colspan="1" rowspan="1">18/7</td><td colspan="1" rowspan="1">15/4</td><td colspan="1" rowspan="1">χ<sup>2</sup> = 4.4</td></tr><tr><td colspan="1" rowspan="1">CDR-SB</td><td colspan="1" rowspan="1">0.1 (0.2)</td><td colspan="1" rowspan="1">6.2 (2.2)<sup>a</sup></td><td colspan="1" rowspan="1">7.2 (2.9)<sup>a</sup></td><td colspan="1" rowspan="1">6.4 (2.5)<sup>a</sup></td><td colspan="1" rowspan="1">69.6<sup>b</sup></td></tr><tr><td colspan="1" rowspan="1">MMSE (maximum score 30)</td><td colspan="1" rowspan="1">28.2 (1.3)</td><td colspan="1" rowspan="1">16.8 (5.0)<sup>a</sup></td><td colspan="1" rowspan="1">15.6 (4.1)<sup>a</sup></td><td colspan="1" rowspan="1">17.4 (4.6) <sup>a</sup></td><td colspan="1" rowspan="1">60.3<sup>b</sup></td></tr><tr><td colspan="1" rowspan="1">WMH visual rating</td><td colspan="1" rowspan="1">4.3 (2.3)</td><td colspan="1" rowspan="1">5.0 (1.3)</td><td colspan="1" rowspan="1">11.2 (4.5) <sup>a,c</sup></td><td colspan="1" rowspan="1">9.2 (4.6) <sup>a,c</sup></td><td colspan="1" rowspan="1">29.3<sup>b</sup></td></tr><tr><td colspan="1" rowspan="1">Patients with cognitive scores</td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1">AD (<italic toggle="yes">n</italic> = 33)</td><td colspan="1" rowspan="1">AD + CeVD (<italic toggle="yes">n</italic> = 20)</td><td colspan="1" rowspan="1">VaD (<italic toggle="yes">n</italic> = 16)</td><td colspan="1" rowspan="1">ANOVA (<italic toggle="yes">F</italic> test)</td></tr><tr><td colspan="1" rowspan="1"> Age</td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1">75.6 (7.6)</td><td colspan="1" rowspan="1">75.1 (5.7)</td><td colspan="1" rowspan="1">73.8 (8.4)</td><td colspan="1" rowspan="1">0.3</td></tr><tr><td colspan="1" rowspan="1"> Sex, F/M</td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1">12/21</td><td colspan="1" rowspan="1">7/13</td><td colspan="1" rowspan="1">10/6</td><td colspan="1" rowspan="1">χ<sup>2</sup> = 3.6</td></tr><tr><td colspan="1" rowspan="1"> Handedness L/R</td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1">0/33</td><td colspan="1" rowspan="1">0/29</td><td colspan="1" rowspan="1">0/16</td><td colspan="1" rowspan="1">–</td></tr><tr><td colspan="1" rowspan="1"> Ethnicity, C/N</td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1">25/8</td><td colspan="1" rowspan="1">14/6</td><td colspan="1" rowspan="1">13/3</td><td colspan="1" rowspan="1">χ<sup>2</sup> = 0.6</td></tr><tr><td colspan="1" rowspan="1"> CDR-SB</td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1">6.3 (2.4)</td><td colspan="1" rowspan="1">7.3 (2.9)</td><td colspan="1" rowspan="1">6.6 (2.6)</td><td colspan="1" rowspan="1">0.9</td></tr><tr><td colspan="1" rowspan="1"> MMSE (maximum score 30)</td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1">16.4 (5.2)</td><td colspan="1" rowspan="1">15.8 (4.5)</td><td colspan="1" rowspan="1">17.4 (4.4)</td><td colspan="1" rowspan="1">0.5</td></tr><tr><td colspan="1" rowspan="1">Visual construction</td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1">0.09 (1.0)</td><td colspan="1" rowspan="1">−0.08 (0.9)</td><td colspan="1" rowspan="1">−0.09 (1.1)</td><td colspan="1" rowspan="1">0.3</td></tr><tr><td colspan="1" rowspan="1">Visual motor</td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1">0.09 (1.1)</td><td colspan="1" rowspan="1">−0.08 (0.9)</td><td colspan="1" rowspan="1">−0.08 (1.0)</td><td colspan="1" rowspan="1">0.2</td></tr><tr><td colspan="1" rowspan="1">Attention</td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1">0.09 (1.1)</td><td colspan="1" rowspan="1">0.02 (0.8)</td><td colspan="1" rowspan="1">−0.21 (1.1)</td><td colspan="1" rowspan="1">0.5</td></tr><tr><td colspan="1" rowspan="1">Executive functioning</td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1">0.17 (1.1)</td><td colspan="1" rowspan="1">−0.18 (0.9)</td><td colspan="1" rowspan="1">−0.13 (1.0)</td><td colspan="1" rowspan="1">0.9</td></tr><tr><td colspan="1" rowspan="1">Language</td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1">0.09 (1.1)</td><td colspan="1" rowspan="1">−0.15 (0.9)</td><td colspan="1" rowspan="1">0 (0.9)</td><td colspan="1" rowspan="1">0.4</td></tr><tr><td colspan="1" rowspan="1">Verbal memory</td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1">−0.07 (1.1)</td><td colspan="1" rowspan="1">−0.22 (0.6)</td><td colspan="1" rowspan="1">0.42 (1.1)</td><td colspan="1" rowspan="1">2.0</td></tr><tr><td colspan="1" rowspan="1">Visuospatial memory</td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1">−0.09 (1.1)</td><td colspan="1" rowspan="1">−0.21 (0.8)</td><td colspan="1" rowspan="1">0.45 (1.1)</td><td colspan="1" rowspan="1">2.3</td></tr></tbody></table><table-wrap-foot><p><italic toggle="yes">Abbreviations: AD</italic> Alzheimer’s disease, <italic toggle="yes">AD + CeVD</italic> Alzheimer’s disease with cerebrovascular disease, <italic toggle="yes">ANOVA</italic> Analysis of variance, <italic toggle="yes">C/N</italic> Chinese/non-Chinese, <italic toggle="yes">CDR-SB</italic> Clinical Dementia Rating Sum of Boxes, <italic toggle="yes">HC</italic> Healthy control subjects, <italic toggle="yes">MMSE</italic> Mini Mental State Examination, <italic toggle="yes">VaD</italic> Vascular dementia, <italic toggle="yes">WMH</italic> White matter hyperintensity</p><p>Values represent mean (SD). The WMH visual rating was measured by the age-related WM change scale score. A subset of patients with complete cognitive scores was used for brain-cognition association analyses</p><p><sup>a</sup> Group mean was different from HC on the basis of post hoc pairwise comparisons (<italic toggle="yes">p</italic> &lt; 0.05)</p><p><sup>b</sup> Group differences at <italic toggle="yes">p</italic> &lt; 0.05 significance level</p><p><sup>c</sup> Group mean was different from the AD group (<italic toggle="yes">p</italic> &lt; 0.05)</p></table-wrap-foot></table-wrap></original-table><transformed-table>Table 1<div xmlns="http://www.w3.org/1999/xhtml" class="caption">Subjects’ clinical and demographic features</div><div xmlns="http://www.w3.org/1999/xhtml" class="table"><table frame="hsides" rules="groups"><thead><tr><th>Groups</th><th>HC (n = 30)</th><th>AD (n = 41)</th><th>AD + CeVD (n = 25)</th><th>VaD (n = 19)</th><th>Overall ANOVA (F test)</th></tr></thead><tbody><tr><td>Age, years</td><td>71.4 (6.7)</td><td>74.9 (8.0)</td><td>75.7 (5.3)</td><td>74.1 (7.2)</td><td>2.4</td></tr><tr><td>Sex, F/M</td><td>15/15</td><td>15/26</td><td>8/17</td><td>11/8</td><td>χ2 = 4.3</td></tr><tr><td>Handedness, L/R</td><td>3/27</td><td>0/41</td><td>0/25</td><td>0/19</td><td>–</td></tr><tr><td>Ethnicity, C/N</td><td>28/2</td><td>33/8</td><td>18/7</td><td>15/4</td><td>χ2 = 4.4</td></tr><tr><td>CDR-SB</td><td>0.1 (0.2)</td><td>6.2 (2.2)a</td><td>7.2 (2.9)a</td><td>6.4 (2.5)a</td><td>69.6b</td></tr><tr><td>MMSE (maximum score 30)</td><td>28.2 (1.3)</td><td>16.8 (5.0)a</td><td>15.6 (4.1)a</td><td>17.4 (4.6) a</td><td>60.3b</td></tr><tr><td>WMH visual rating</td><td>4.3 (2.3)</td><td>5.0 (1.3)</td><td>11.2 (4.5) a,c</td><td>9.2 (4.6) a,c</td><td>29.3b</td></tr><tr><td>Patients with cognitive scores</td><td/><td>AD (n = 33)</td><td>AD + CeVD (n = 20)</td><td>VaD (n = 16)</td><td>ANOVA (F test)</td></tr><tr><td> Age</td><td/><td>75.6 (7.6)</td><td>75.1 (5.7)</td><td>73.8 (8.4)</td><td>0.3</td></tr><tr><td> Sex, F/M</td><td/><td>12/21</td><td>7/13</td><td>10/6</td><td>χ2 = 3.6</td></tr><tr><td> Handedness L/R</td><td/><td>0/33</td><td>0/29</td><td>0/16</td><td>–</td></tr><tr><td> Ethnicity, C/N</td><td/><td>25/8</td><td>14/6</td><td>13/3</td><td>χ2 = 0.6</td></tr><tr><td> CDR-SB</td><td/><td>6.3 (2.4)</td><td>7.3 (2.9)</td><td>6.6 (2.6)</td><td>0.9</td></tr><tr><td> MMSE (maximum score 30)</td><td/><td>16.4 (5.2)</td><td>15.8 (4.5)</td><td>17.4 (4.4)</td><td>0.5</td></tr><tr><td>Visual construction</td><td/><td>0.09 (1.0)</td><td>−0.08 (0.9)</td><td>−0.09 (1.1)</td><td>0.3</td></tr><tr><td>Visual motor</td><td/><td>0.09 (1.1)</td><td>−0.08 (0.9)</td><td>−0.08 (1.0)</td><td>0.2</td></tr><tr><td>Attention</td><td/><td>0.09 (1.1)</td><td>0.02 (0.8)</td><td>−0.21 (1.1)</td><td>0.5</td></tr><tr><td>Executive functioning</td><td/><td>0.17 (1.1)</td><td>−0.18 (0.9)</td><td>−0.13 (1.0)</td><td>0.9</td></tr><tr><td>Language</td><td/><td>0.09 (1.1)</td><td>−0.15 (0.9)</td><td>0 (0.9)</td><td>0.4</td></tr><tr><td>Verbal memory</td><td/><td>−0.07 (1.1)</td><td>−0.22 (0.6)</td><td>0.42 (1.1)</td><td>2.0</td></tr><tr><td>Visuospatial memory</td><td/><td>−0.09 (1.1)</td><td>−0.21 (0.8)</td><td>0.45 (1.1)</td><td>2.3</td></tr></tbody></table></div>Abbreviations: AD Alzheimer’s disease, AD + CeVD Alzheimer’s disease with cerebrovascular disease, ANOVA Analysis of variance, C/N Chinese/non-Chinese, CDR-SB Clinical Dementia Rating Sum of Boxes, HC Healthy control subjects, MMSE Mini Mental State Examination, VaD Vascular dementia, WMH White matter hyperintensityValues represent mean (SD). The WMH visual rating was measured by the age-related WM change scale score. A subset of patients with complete cognitive scores was used for brain-cognition association analysesa Group mean was different from HC on the basis of post hoc pairwise comparisons (p &lt; 0.05)b Group differences at p &lt; 0.05 significance levelc Group mean was different from the AD group (p &lt; 0.05)</transformed-table></extracted-table></extracted-tables-set>